Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Associate Attending Physician
Dr Heather J. Landau, MD, is an Associate Attending Physician on the Adult Bone Marrow Transplant, Cellular Therapy, and Multiple Myeloma services at Memorial Sloan Kettering (MSK) Cancer Center. She is the Director of the Amyloidosis Program, where she leads a multidisciplinary group focused on clinical and translational research to improve outcomes for patients with AL amyloidosis.Dr Landau has… View more
Author(s): Added: 8 months ago
Discover the rapidly evolving therapeutic options transforming outcomes for cardiac amyloidosis patients with Dr Sarah Cuddy.This comprehensive presentation, part of the Cardiomyopathies track, explores the dramatic advances in both TTR and AL amyloidosis treatment over the past decade. Dr Cuddy examines how modern therapeutic approaches have fundamentally shifted survival curves, particularly… View more
Author(s): Erwan Donal Added: 1 month ago
ACC 2026 - Two randomised trials position TriClip TEER as a transformative option in TR, delivering significant reductions in heart failure hospitalisations and supporting earlier intervention in clinical practice.Prof Erwan Donal (Hospital Pontchaillou of Rennes, Rennes, FR) joins us on-site at ACC 2026 to share the findings from two randomised trials (Tri.Fr and TRILUMINATE Pivotal)… View more
Job title: Consultant Paediatric Cardiologist
Professor Shakeel Qureshiis a London based paediatric cardiologistwhose achievements include interventions incongenital heart disease. He carries out a variety of interventions inpaediatricandadult congenital cardiology, including ballooning of arteries and valves. He has developed innovative keyhole procedures as aconsultant paediatric cardiologistatGuy’s and St Thomas’ Hospital Trustand has… View more
Job title: Editor-in-Chief, US Cardiology Review
Dr Gogas has more than 10 years of clinical and research experience in cardiology/interventional cardiology. He is current faculty at Nanjing University in China and formerly held a position in the Division of Cardiology of Emory University School of Medicine at the rank of Instructor of Medicine. He received his PhD from Erasmus University, Rotterdam, in 2014 under the mentorship of Prof Patrick… View more
Author(s): Julius Nikorowitsch Added: 2 years ago
EHRA 24 - We are joined onsite by Dr Julius Nikorowitsch (University Heart and Vascular Centre Hamburg (UHZ), DE) to outline the impact of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation in a substudy of the NOAH-AFNET 6 trial (NCT02618577).The substudy consisted of 2534 patients from… View more
Author(s): Pam Taub , Nikolaus Marx Added: 1 year ago
RP-UN-CAR-GB-0166 / June 2024This programme features a compelling discussion between two distinguished experts, Prof Pam Taub (University of California, San Diego, US) and Prof Nikolaus Marx (University Hospital RWTH, Aachen, DE), chairperson responsible for the most recent ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. Together, they delve into a critical… View more
Author(s): Daniel Scherr Added: 1 year ago
AF Symposium 25 - The MANIFEST-REDO sub-study suggests repeat ablation procedures due to clinical recurrence of atrial fibrillation (AF) can be performed safely and with an acceptable success rate.Prof Daniel Scherr (Medical University, Graz, AT) joins us onsite at AF Symposium 25 to discuss the insights from MANIFEST-REDO, investigating repeated ablation following pulmonary vein isolation (PVI)… View more